menu
    • menu

    Company profile for Axon Neuroscience

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Axon Neuroscience is a clinical-stage biotech company developing disease-modifying immunotherapeutics for Alzheimer's disease and Frontotemporal lobar degeneration. Ground-breaking discoveries in Alzheimer’s disease research made by AXON Neuroscience enabled the company to create a therapeutic platform of global importance. The target products of strategic importance in this platform are revolutionary therapeutic candidate v...
    Axon Neuroscience is a clinical-stage biotech company developing disease-modifying immunotherapeutics for Alzheimer's disease and Frontotemporal lobar degeneration. Ground-breaking discoveries in Alzheimer’s disease research made by AXON Neuroscience enabled the company to create a therapeutic platform of global importance. The target products of strategic importance in this platform are revolutionary therapeutic candidate vaccines for treatment of Alzheimer's disease and Frontotemporal lobar degeneration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Axon NeuroscienceCyprus Flag
    Country
    Country
    Cyprus
    Address
    Address
    Arch. Makariou & Kalogreon 4 Nicolaides Sea View City Block C, 5th floor Offic...
    Telephone
    Telephone
    +357 2425 2636
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.axon-neuroscience.eu/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axon Neuroscience Joins $151M U.S. Alzheimer's Clinical Trial
    Axon Neuroscience Joins $151M U.S. Alzheimer's Clinical Trial

    04 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-04/axon-neurosciences-immunotherapy-selected-for-a-landmark-combination-therapy-alzheimer-s-clinical-t

    PHARMIWEB
    04 Feb 2026
    Share Share
    AXON Neuroscience to Present New Results from Phase II Clinical Study
    AXON Neuroscience to Present New Results from Phase II Clinical Study

    27 Jul 2021

    // ACCESSWIRE

    https://www.accesswire.com/657035/AXON-Neuroscience-to-Present-New-Results-from-Phase-II-Clinical-Study-at-2021-Alzheimers-Association-International-Conference

    ACCESSWIRE
    27 Jul 2021
    Share Share
    AXON Neuroscience to Present New Results from Phase II Clinical Study
    AXON Neuroscience to Present New Results from Phase II Clinical Study

    27 Jul 2021

    // ACCESSWIRE

    https://www.accesswire.com/657035/AXON-Neuroscience-to-Present-New-Results-from-Phase-II-Clinical-Study-at-2021-Alzheimers-Association-International-Conference

    ACCESSWIRE
    27 Jul 2021
    Share Share
    Nature Aging publishes phase II results for AADvac1
    Nature Aging publishes phase II results for AADvac1

    16 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nature-aging-publishes-phase-ii-results-for-aadvac1-a-first-in-man-alzheimers-tau-vaccine-developed-by-axon-neuroscience-301311724.html

    PRNEWSWIRE
    16 Jun 2021
    Share Share
    Nature Aging publishes phase II results for AADvac1
    Nature Aging publishes phase II results for AADvac1

    15 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nature-aging-publishes-phase-ii-results-for-aadvac1-a-first-in-man-alzheimers-tau-vaccine-developed-by-axon-neuroscience-301311724.html

    PRNEWSWIRE
    15 Jun 2021
    Share Share
    Nature Aging publishes phase II results for AADvac1
    Nature Aging publishes phase II results for AADvac1

    14 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nature-aging-publishes-phase-ii-results-for-aadvac1-a-first-in-man-alzheimers-tau-vaccine-developed-by-axon-neuroscience-301311724.html

    PRNEWSWIRE
    14 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search